机器学习识别糖尿病患者中的代谢功能障碍相关脂肪性肝病
研究纳入2000例糖尿病患者,通过特征选择确定8个判别参数并构建多元逻辑回归机器学习模型识别MASLD。模型在1735例中AUC为0.84(95%CI 0.82-0.86),敏感度0.75、特异度0.79;265例测试集中AUC为0.81(95%CI 0.76-0.87)。作者认为该机器学习方法在识别糖尿病患者MASLD方面表现良好,可能有助于风险分层和心血管风险预防。
要点
- 8个判别参数:年龄、体重指数、糖尿病类型、丙氨酸氨基转移酶、天冬氨酸氨基转移酶、血小板计数、高尿酸血症和二甲双胍治疗。
- 模型在1735例中正确识别有/无MASLD患者分别为744/991(75.08%)和586/744(78.76%),敏感度/特异度0.75/0.79。
- 测试集265例中敏感度/特异度0.80/0.74,AUC 0.81(95%CI 0.76-0.87),无监督聚类识别高危患者。
核心结论
- 机器学习方法在识别糖尿病患者MASLD方面表现出高性能。
- 该方法可能有助于对存在MASLD风险的糖尿病患者进行更好的风险分层和心血管风险预防策略。
研究设计与样本
- 研究纳入2000例糖尿病患者(平均年龄58.85±17.37岁;48%为女性),通过特征选择确定判别参数,构建多元逻辑回归机器学习模型对糖尿病患者进行MASLD有无分类。
主要发现
- 在1735例患者的实验中,有MASLD患者744/991(75.08%)和无MASLD患者586/744(78.76%)被正确识别,敏感度/特异度分别为0.75/0.79。
- ROC曲线下面积(AUC)为0.84(95%CI 0.82-0.86),决策曲线分析显示模型在30%至84%阈值概率范围内具有更高的临床效用。
- 265例测试患者结果证实模型泛化性:敏感度/特异度0.80/0.74,AUC 0.81(95%CI 0.76-0.87),无监督聚类识别出高危患者。
临床怎么用
- 作者认为该机器学习方法可能有助于对存在MASLD风险的糖尿病患者进行更好的风险分层和心血管风险预防策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The presence of metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with diabetes mellitus (DM) is associated with a high risk of cardiovascular disease, but is often underdiagnosed. OBJECTIVE: To develop machine learning (ML) models for risk assessment of MASLD occurrence in patients with DM. METHODS: Feature selection determined the discriminative parameters, utilized to classify DM patients as those with and without MASLD. The performance of the multiple logistic regression model was quantified by sensitivity, specificity, and percentage of correctly classified patients, and receiver operating characteristic (ROC) curve analysis. Decision curve analysis (DCA) assessed the model's net benefit for alternative treatments. RESULTS: We studied 2000 patients with DM (mean age 58.85 ± 17.37 years; 48% women). Eight parameters: age, body mass index, type of DM, alanine aminotransferase, aspartate aminotransferase, platelet count, hyperuricaemia, and treatment with metformin were identified as discriminative. The experiments for 1735 patients show that 744/991 (75.08%) and 586/744 (78.76%) patients with/without MASLD were correctly identified (sensitivity/specificity: 0.75/0.79). The area under ROC (AUC) was 0.84 (95% CI, 0.82-0.86), while DCA showed a higher clinical utility of the model, ranging from 30% to 84% threshold probability. Results for 265 test patients confirm the model's generalizability (sensitivity/specificity: 0.80/0.74; AUC: 0.81 [95% CI, 0.76-0.87]), whereas unsupervised clustering identified high-risk patients. CONCLUSION: A ML approach demonstrated high performance in identifying MASLD in patients with DM. This approach may facilitate better risk stratification and cardiovascular risk prevention strategies for high-risk patients with DM at risk of MASLD.
引用
- Nabrdalik K, Kwiendacz H, Irlik K, et al. Machine Learning Identifies Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Diabetes Mellitus. J Clin Endocrinol Metab. 2024. PMID: 38330228. doi:10.1210/clinem/dgae060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。